Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 424.5 GBX -0.47%
Market Cap: 449.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Wall Street
Price Targets

OXB Price Targets Summary
Oxford BioMedica PLC

Wall Street analysts forecast OXB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OXB is 550.22 GBX with a low forecast of 383.8 GBX and a high forecast of 777 GBX.

Lowest
Price Target
383.8 GBX
10% Downside
Average
Price Target
550.22 GBX
30% Upside
Highest
Price Target
777 GBX
83% Upside
Oxford BioMedica PLC Competitors:
Price Targets
IDYA
IDEAYA Biosciences Inc
118% Upside
BVXP
Bioventix PLC
58% Upside
301207
Hualan Biological Bacterin Inc
63% Upside
SRPT
Sarepta Therapeutics Inc
58% Upside
MAB
Mabion SA
37% Upside
GLPG
Galapagos NV
40% Upside
ACHV
Achieve Life Sciences Inc
342% Upside
688428
InnoCare Pharma Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
Oxford BioMedica PLC

For the last 8 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 4 years is 28%.

24%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OXB's stock price target?
Price Target
550.22 GBX

According to Wall Street analysts, the average 1-year price target for OXB is 550.22 GBX with a low forecast of 383.8 GBX and a high forecast of 777 GBX.

What is Oxford BioMedica PLC's Revenue forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 4 years is 28%.

Back to Top